Balancing innovation and human rights in genetics

Introduction

Balancing Innovation and Human Rights in Genetics refers to the legal, ethical, and regulatory process of ensuring that scientific developments in genetics do not violate fundamental human rights, individual dignity, privacy, equality, and personal autonomy. Modern genetic technologies, including genome sequencing, gene editing, genetic testing, genetic engineering, and reproductive genetics, have created significant opportunities for preventing inherited diseases, improving medical diagnosis, and developing personalised treatments.

Technologies such as CRISPR-Cas9 have made it possible to modify specific genetic sequences, potentially offering new approaches to treating hereditary disorders. Similarly, genomic databases help researchers understand genetic variations and develop targeted medical interventions.

However, these developments also create serious concerns regarding genetic discrimination, unauthorised use of biological samples, privacy violations, reproductive autonomy, unequal access to treatment, and the possibility of unethical genetic modification.

The central challenge of genetic governance is therefore to encourage scientific innovation while ensuring that technological advancement remains consistent with constitutional protections, international human rights standards, and ethical research principles.

Legal framework governing genetic innovation

Genetic research is regulated through national legislation, international conventions, constitutional principles, and institutional ethical guidelines.

1. Constitutional protection under the Indian Constitution

The Indian Constitution provides several fundamental rights relevant to genetic research.

Article 14 guarantees equality before the law and equal protection of laws.

Article 19 protects specified freedoms, subject to constitutional restrictions.

Article 21 protects life and personal liberty, including privacy, dignity, and personal autonomy.

These provisions are important when genetic technologies affect reproductive decisions, medical treatment, personal identity, or access to healthcare.

For example, employers and insurance providers should not use genetic information in ways that violate applicable equality, privacy, or other legal protections.

2. Information Technology Act, 2000

The Information Technology Act, 2000, provides a framework for electronic information security and certain forms of unauthorised access and misuse of computer systems.

Genetic databases containing identifiable personal information require appropriate security safeguards.

The Digital Personal Data Protection Act, 2023, also establishes a framework for processing digital personal data, subject to its applicable commencement and rules.

3. New Drugs and Clinical Trials Rules, 2019

These rules provide a regulatory framework for clinical trials involving new drugs and investigational new drugs in India.

Where genetic technologies are investigated as therapeutic interventions, applicable clinical trial permissions, ethics committee approvals, informed consent requirements, and participant protection standards must be followed.

4. Biological Diversity Act, 2002

Genetic research involving biological resources and associated traditional knowledge may also attract obligations under the Biological Diversity Act, 2002, as amended in 2023.

The legislation addresses access to biological resources and associated benefit-sharing requirements, subject to its applicable provisions and exemptions.

Human rights concerns in genetic research

1. Genetic privacy and confidentiality

Genetic information can reveal important details about an individual's health, inherited conditions, biological relationships, and potential disease risks.

Unlike many other categories of personal information, genetic information may also reveal information about biological relatives.

Therefore, genetic research institutions must establish appropriate consent procedures, confidentiality safeguards, secure data storage, and restrictions on unauthorised disclosure.

Participants should understand whether their genetic information will be used only for the original research project or whether it may also be used in future investigations.

2. Genetic discrimination

Genetic discrimination occurs when individuals receive unfair treatment because of their genetic characteristics or predicted disease risks.

For example, an employer might attempt to exclude an applicant because genetic testing indicates a possible future medical condition.

Such practices raise serious concerns relating to equality, privacy, and human dignity.

Legal frameworks should prevent unjustified discrimination based on genetic characteristics and ensure that genetic information is not misused for employment, insurance, or social exclusion.

3. Gene editing and human dignity

Gene-editing technologies create opportunities to investigate and potentially treat genetic diseases.

However, concerns arise when genetic modifications involve reproductive cells or embryos because certain changes may be transmitted to future generations.

The distinction between somatic gene editing and germline gene editing is particularly important.

Somatic gene editing affects cells within an individual and generally does not pass genetic modifications to future generations. Germline modifications may be inherited by subsequent generations.

Consequently, research involving human germline modification requires particularly stringent ethical and legal oversight.

4. Reproductive autonomy and informed consent

Genetic testing and reproductive technologies may influence decisions concerning pregnancy, embryo selection, and inherited disease prevention.

Individuals must receive accurate information about testing limitations, possible outcomes, and available alternatives.

Informed consent should be voluntary and based on adequate scientific explanations.

Researchers must also avoid coercive practices and respect the reproductive autonomy and dignity of participants.

International human rights framework

Several international instruments provide important principles for balancing genetic innovation and human rights.

Universal Declaration on the Human Genome and Human Rights, 1997: Adopted by UNESCO, this declaration emphasises human dignity, individual rights, and protection against genetic discrimination.

International Covenant on Civil and Political Rights, 1966: Article 17 protects individuals against arbitrary or unlawful interference with privacy.

International Covenant on Economic, Social and Cultural Rights, 1966: Article 12 recognises the right to the highest attainable standard of physical and mental health.

Convention on Biological Diversity, 1992: Establishes principles concerning biodiversity conservation, sustainable use, and fair benefit-sharing.

Together, these instruments provide a foundation for responsible genetic research and equitable distribution of scientific benefits.

Important judicial decisions

1. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

The Supreme Court of India recognised privacy as a fundamental right under Article 21 of the Constitution.

The judgment is highly relevant to genetic research because genomic information can reveal deeply personal information about individuals and their biological relatives.

It supports the requirement for privacy safeguards, lawful information processing, and protection against arbitrary interference with personal autonomy.

2. Common Cause v. Union of India (2018)

The Supreme Court examined individual autonomy, dignity, and the right to die with dignity in the context of passive euthanasia and advance medical directives.

Although the case did not concern genetic engineering, its recognition of individual autonomy and dignity provides important constitutional principles for medical research and decisions involving advanced genetic technologies.

3. Suchita Srivastava v. Chandigarh Administration (2009)

The Supreme Court recognised reproductive autonomy as an important aspect of personal liberty under Article 21.

The judgment is relevant to reproductive genetics because genetic testing and reproductive interventions may influence deeply personal decisions concerning pregnancy and reproductive healthcare.

4. Selvi v. State of Karnataka (2010)

The Supreme Court examined the constitutional implications of involuntary narcoanalysis, polygraph examinations, and brain electrical activation profiling.

The judgment emphasised personal liberty, mental privacy, and protection against involuntary investigative techniques.

Its broader constitutional principles are relevant when considering whether genetic testing or biological investigations may be undertaken without valid consent.

5. Nandini Satpathy v. P.L. Dani (1978)

The Supreme Court examined the protection against compelled self-incrimination under Article 20(3).

Although the case did not involve genetic testing, it is relevant to broader questions about individual autonomy and the constitutional limitations on compelled disclosure of personal information.

Ethical governance and regulatory safeguards

Effective genetic governance requires cooperation between governments, research institutions, medical professionals, biotechnology companies, and ethics committees.

Important safeguards include:

Informed consent: Participants must understand the purpose, risks, and potential consequences of genetic research.

Data protection: Genetic information must be stored securely and accessed only for authorised purposes.

Independent ethical review: Research involving human participants must undergo appropriate ethics committee assessment.

Scientific transparency: Researchers must disclose limitations, uncertainties, and potential risks.

Non-discrimination: Genetic information should not become a basis for unjustified exclusion or unequal treatment.

Equitable access: The benefits of genetic innovation should not remain restricted to economically privileged populations.

International cooperation: Cross-border genetic research should respect applicable privacy, research, and biodiversity regulations.

Regulatory institutions should also distinguish between experimental research, approved medical applications, and commercial genetic services. Each category may require different levels of oversight.

Conclusion

Balancing innovation and human rights in genetics is essential for ensuring that scientific progress remains consistent with human dignity, equality, privacy, and individual autonomy.

Genetic technologies have considerable potential to prevent inherited diseases, improve diagnosis, and develop personalised medical treatments. However, their development must be accompanied by strong safeguards against genetic discrimination, unauthorised data processing, coercive testing, and unethical genetic modification.

Indian constitutional decisions, particularly Justice K.S. Puttaswamy v. Union of India (2017), Suchita Srivastava v. Chandigarh Administration (2009), and Selvi v. State of Karnataka (2010), provide important principles concerning privacy, reproductive autonomy, and personal liberty.

Ultimately, responsible genetic innovation requires a balanced legal framework that encourages scientific discovery while protecting present and future generations from misuse of genetic technologies.